Chengdu Kanghua Biological Products (300841) — Capital Reinvestment Ratio
Chengdu Kanghua Biological Products (300841) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥92.89 Million) in capital expenditures (CN¥14.49 Million). Check Chengdu Kanghua Biological Products tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chengdu Kanghua Biological Products Capital Reinvestment Ratio (2015–2024)
This chart tracks Chengdu Kanghua Biological Products's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Chengdu Kanghua Biological Products operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year Capital Reinvestment Ratio for Chengdu Kanghua Biological Products from 2015 to 2024. See Chengdu Kanghua Biological Products (300841) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥572.24 Million | CN¥144.30 Million | ▼ -8.0% |
| 2023 | 0.27x | CN¥573.98 Million | CN¥157.27 Million | ▼ -87.3% |
| 2022 | 2.15x | CN¥194.99 Million | CN¥419.23 Million | ▼ -11.0% |
| 2021 | 2.42x | CN¥130.33 Million | CN¥314.94 Million | ▲ +558.3% |
| 2020 | 0.37x | CN¥369.56 Million | CN¥135.67 Million | ▲ +179.1% |
| 2019 | 0.13x | CN¥182.73 Million | CN¥24.04 Million | ▼ -78.2% |
| 2018 | 0.60x | CN¥57.35 Million | CN¥34.58 Million | ▲ +1096.9% |
| 2017 | 0.05x | CN¥89.96 Million | CN¥4.53 Million | ▼ -92.8% |
| 2016 | 0.70x | CN¥2.64 Million | CN¥1.86 Million | ▲ +48.7% |
| 2015 | 0.47x | CN¥6.51 Million | CN¥3.07 Million | — |